Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

¥15.89As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301246Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (20.52%)
Div yield 0.31%
ROE 6.75%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.05
PE TTM 20.88
TSR TTM (17.74%)
Mkt cap ¥6.305B
ROIC 7.19%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥17
5.80%
(60.88%)
Hold 3|3|4|10|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.14
0.14
0.13
(3.38%)
(2.81%)
(1.31%)
(2.95%)
Revenue¥M
801.6
837.1
838.8
819.0
(3.15%)
4.02%
3.95%
3.04%
Peers (US$945.2M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.593
0.370
0.268
EBIT/Intx
1.824
0.300
0.332
Own earn%
(173.59)
(12.84)
(21.13)
Sh yield%
25.08
47.28
47.03
Owners
Insiders/Inst%
11.30
33.83
Short interest%
5.15
SBC / revenue%
5.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
1–7
$1 testx
0.0
Incr. ROIC%
12